Clinical Trial Update: Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH [Phase 3]

View source ↗

Summary

A phase 3 open-label randomized trial evaluated the safety and efficacy of bivalirudin versus unfractionated heparin in patients undergoing transcatheter aortic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Angiomax (bivalirudin) (bivalirudin)
• Heparin (unfractionated) (unfractionated heparin)

Snippet

Sponsor: The Medicines Company | Conditions: Severe Aortic Stenosis, Transcatheter Aortic Valve Replacement | Phase 3 | Status: COMPLETED | Results posted: 2017-02-27